Home

Who we are
> Michele Brill-Edwards
> Helen Chan
> John Dick
> Peter Durie
> Brenda Gallie
> Marc Giacomelli
> Miriam Kaufman
> Nancy Olivieri
> Paul Ranalli
> Margaret Thompson

Why we exist
In the news
The Experts speak
Upcoming events
How to help

BRENDA L. GALLIE, MD, FRCS(C).

  • Medical Research Council of Canada Distinguished Scientist
  • Professor of Ophthalmology, Molecular & Medical Genetics and Medical Biophysics, University of Toronto
  • Founding member of the Canadian Genetic Disease Network, a National Center of Excellence
  • Head of the Division of Cancer Informatics, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network
  • 1998 Recipient of the O. Harold Warwick Prize of the National Cancer Institute of Canada
  • Senior Scientist of the Hospital for Sick Children Research Institute.

Dr. Gallie is an Ophthalmologist who has focused on the rare cancer in children, retinoblastoma. These studies have contributed significantly to the basic molecular understanding of cancer in general, to applications for molecular diagnosis in healthcare and to clinical trials with novel Internet use. Dr. Gallie is a Distinguished Scientist of the Canadian Institutes for Health Research and has been a member of the Board of Scientific Counselors for the National Cancer Institute, NIH. She founded "World Retinoblastoma", which is dedicated to creating a world-wide network of centers of excellence in retinoblastoma clinical care and to working with governments and institutions to achieve access for every family to optimal care while maintaining family structures. She is the president and founder of a start up company that has emerged from 15 years of translational research that has developed efficient and effective technologies to identify mutations in the retinoblastoma gene for families. The new company is providing a unique diagnostic service to a world market.

Dr. Gallie is presently Director of the Retinoblastoma Program at The Hospital for Sick Children and Head of the Division of Cancer Informatics at the Ontario Cancer Institute. She continues to care for children with retinoblastoma, lead a basic science group working to identify precisely why children get retinoblastoma, and is leading world clinical trials and databanks.

 
Copyright 2001 Doctors for Research Integrity.